| Code | 2216D | ||||||||||
| MA number | 20/0240/19-S | ||||||||||
| Product Form: | tbl 50x20 mg/40 mg (blis.PA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 05.08.2019 |
| Validity: | 05.08.2024 |
| MA renewed: | Renewal application submitted |
| PIL: |
PIL_MEDOVERT 20 mg_40 mg tablety_03_2025.pdf
|
| SPC: |
SPC_MEDOVERT 20 mg_40 mg tablety_03_2025.pdf
|
| Safety feature | Yes |
| Data update: | 06.08.2019 |
